Noticias de NBY_US

Noticias del mercado

Últimas noticias sobre NBY_US — 96 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: NBY_US ✕ 96 resultados
24/03/2026 NBY_US — minichart.com.sg
NovaBay Pharmaceuticals to Rebrand as Stablecoin Development Corporation, Announces SKY Token Holdings and NYSE Ticker Change to SDEV 121314181920
23/03/2026 NBY_US — The Globe and Mail
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
23/03/2026 NBY_US — Yahoo Finance
NovaBay Rebrands To Stablecoin Development Corp, Shares Jump 12 Percent
23/03/2026 NBY_US — The Manila Times
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
23/03/2026 NBY_US — Blockonomi
Stablecoin Development Corp (SDEV): Former NovaBay Completes $147M SKY Token Acquisition and Corporate Rebrand
23/03/2026 NBY_US — FinancialContent
Upcoming Events
23/03/2026 NBY_US — MEXC Exchange
Pharmaceutical Stock Jumps 26% on Crypto Pivot Plan
23/03/2026 NBY_US — MEXC Exchange
Pharmaceutical Stock Jumps 26% on Crypto Pivot Plan
23/03/2026 NBY_US — Stock Titan
After $134M deal, NovaBay rebrands around 2.06B SKY tokens
23/03/2026 NBY_US — TheStreet
Pharmaceutical stock surges 26% after crypto pivot
23/03/2026 NBY_US — Stock Titan
NovaBay (NYSE: NBY) pivots to Stablecoin Development Corp and SDEV ticker
23/03/2026 NBY_US — CoinCentral
NovaBay Pharmaceuticals (NBY) Stock: Rebrands as Stablecoin Development Corp, Acquires $147M in SKY Tokens
23/03/2026 NBY_US — Whalesbook ES ← EN
NovaBay Pharma se convierte en SDEV y apuesta 134 millones de dólares en el token Sky Protocol
23/03/2026 NBY_US — MoneyCheck
Stablecoin Development Corp (SDEV): Former NovaBay Completes $147M SKY Token Acquisition
23/03/2026 NBY_US — The Block
Biotech stock NovaBay jumps 19% amid pivot, rebrand to Stablecoin Development Corporation
20/03/2026 NBY_US — Minichart
NovaBay Pharmaceuticals, Inc. 2025 Annual Report: Financials, Stock Warrants, Preferred Stock, and Corporate Actions

Página 5 de 5

keyboard_arrow_up